Copyright
©The Author(s) 2021.
World J Gastroenterol. Dec 28, 2021; 27(48): 8302-8322
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8302
Published online Dec 28, 2021. doi: 10.3748/wjg.v27.i48.8302
Category | Sequence (5’-3’) |
miR-135a-5p mimic | F-UAUGGCUUUUUAUUCCUAUGUGA |
R-UCACAUAGGAAUAAAAAGCCAUA | |
miR-135a-5p inhibitor | UCACAUAGGAAUAAAAAGCCAUA |
VAMP2 (NM_001330125.1) | F-CTAGCTAGCATGGACAGGTCTGCTAC |
R-CGCGGATCCTTAAGTGCTGAAGT | |
VAMP2 3’-UTR-WT | F-CTAGCTAGCATCCCCGAGGAGTCT |
R-ACGCGTCGACAGAGAGGGGTGAAG | |
VAMP2 3’-UTR-MUT | F-GTTCCTCCACCTCTCACGTGCATCTTTCAGCC CC |
R-GGGGCTGAAAGATGCACGTGAGAGGTGGAGGAAC | |
Hepatitis B virus-1903/2454 | F-CTAGCTAGCGCCACCATGGACATCGACCCTT |
R-CCGCTCGAGCTAACATTGAGATTCCCGAGAT |
- Citation: Wei XC, Xia YR, Zhou P, Xue X, Ding S, Liu LJ, Zhu F. Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma. World J Gastroenterol 2021; 27(48): 8302-8322
- URL: https://www.wjgnet.com/1007-9327/full/v27/i48/8302.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i48.8302